Haleon PLC (HLN.L) Stock Forecast
LSE · Healthcare
Current price
£3.48
Market cap
£30.69B
Mean price target
£4.14
Implied upside
18.8%
Key takeaways
- Analysts rate Haleon PLC a “Buy”, with a mean price target of £4.14 — about 18.8% upside from the current £3.48, based on 17 analysts.
- HLN.L is trading in the middle of its 52-week range, at 52% of the £2.74–£4.16 band.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 17 |
| Mean target | £4.14 |
| High target | £5.12 |
| Low target | £3.15 |
| Rating split (SB / B / H / S / SS) | 3 / 9 / 3 / 1 / 1 |
Price & trading
| Current price | £3.48 |
|---|---|
| Previous close | £3.48 |
| 52-week high | £4.16 |
| 52-week low | £2.74 |
| 50-day average | £3.39 |
| Beta | 0.25 |
See the full HLN.L breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Haleon PLC (HLN.L) share price?
- Haleon PLC last traded at £3.48 with a market capitalisation of about £30.7B.
- What is the analyst price target for HLN.L?
- The mean analyst price target for Haleon PLC is £4.14, roughly 18.8% above the latest price. The current consensus rating is “Buy”.
- Where can I see Haleon PLC's full financial metrics?
- Luminoso tracks HLN.L's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.